Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

Novo's Ozempic is approved by the U.S. Food and Drug Administration ... This year, the FDA approved the company's Alzheimer's ...

Taxi and ambulance drivers have jobs that "demand real-time spatial and navigational processing," said the lead researcher, ...

Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes “The same part of the brain that’s involved in creating cognitive spatial maps — which we use to navigate ...

Taxi and ambulance drivers are at a lower risk of an Alzheimer's disease-related death, a new study finds. Related: Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 ...

Novo Nordisk is running three late-stage trials of semaglutide, the active ingredient in its Ozempic and Wegovy drugs, for ...